Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by pentad2on May 26, 2010 12:50pm
439 Views
Post# 17132662

RE: RE: Is there any upside?

RE: RE: Is there any upside?The problem is they are running out of cash.They currently have enough to get them thru to the end of the year.If those warrants were bought by june 30 they would have received 7 million.If they have to go to the market for 7 million say at .10 that's another 70 million shares.If there was a mix up in the way the testing was done i think there will be an oppurtunity to get back in.A lot of the trust people had in this company is gone with the way things have gone in the last week.
I think i'm going to sit on the sidelines and watch and see what happens.
Bullboard Posts